Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Cytochrome P45O 2El È¿¼ÒÀ¯ÀüÀÚ ´ÙÇü¼ººÐ¼®À» ÅëÇÑ ÀڱðæºÎ¾ÏÀÇ À¯ÀüÀû °¨¼ö¼º¿¡ °üÇÑ ¿¬±¸ Cytochrome P45O 2El Polymorphisms and Genetic Susceptibility to Cervical Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 3È£ p.429 ~ 436
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁø¿ì ÀÌÃá±Ù/¼Õ¿©¿ø/¹ÎÈ«±â/ÀÌ°æ¿í/±Ç³çÁÖ/°íÇö¼÷/½ÅÁø¿õ/±èÈï±â

Abstract

°á·Ð
360¸íÀÇ Á¤»ó´ëÁ¶±º°ú 228¸íÀÇ ÀڱðæºÎ¾Ï ȯÀÚ±ºÀ» ´ë»óÀ¸·Î ÀڱþϿ¡ ´ëÇÑ À¯ÀüÀû °¨¼ö
¼º°áÁ¤¿¡ ±â¿©ÇÏ´Â ÀÎÀÚ¸¦ ±Ô¸íÇϱâ À§ÇØ cytochrome P-450(CYP)È¿¼ÒÀÇ CYP 2E1/PstI ¶Ç
´Â, CYP 221/fso1°ú CYP 2E1/RsaaI ´ÙÇü¼ºµîÀ» ºÐ¼®ÇÑ °á°ú CYP 2El ´ÙÇü¼ºÀº ÀڱðæºÎ
¾Ï¿¡ ÀÌȯµÉ À¯ÀüÀû °¨¼ö¼º °áÁ¤¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏÁö ¾Ê´Â °ÍÀ¸·Î ¹àÇôÁ³À¸¸ç 40¼¼ ÀÌÇÏ
ÀÇ ÀþÀº ¿¬·É¿¡¼­ ¹ß»ýÇÏ´Â ÀڱðæºÎ¾ÏÀÇ À¯ÀüÀû °¨¼ö¼º¿¡µµ °ü¿©ÇÏÁö ¾Ê´Â °ÍÀ¸·Î ³ªÅ¸³µ
´Ù. ¶ÇÇÑ, CYP 2El À¯ÀüÀÚ ´ÙÇü¼ºÀº ÀڱðæºÎ¾ÏÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¼ºµéÁß Á¾¾çÀÇ ÁøÇàÀ̳ª
¾Ç¼ºµµ¿¡µµ °ü¿©ÇÏÁö ¾Ê´Â °ÍÀ¸·Î ÆǸíµÇ¾ú´Ù.

Purpose : Interindividual genetic differences in susceptibility to chemical carcinogens
are one of the most important host factors in human cancer. The genetically determined
differences in metabolism, related to cytochrome P45O (CYP450) genes have been
reported to be associated with various cancer susceptibility. The present study was set
of to establish the frequency of the polymorphic genotypes of two CYP450 (CYP2E1/PstI
and CYP2E1/Dral) isozymes in Korea, to evaluate a possible increased incidence of the
genotype associated with higher conical cancer risks among Korean cervical cancer
patients.
Materials and Methods : In this study, extracted DNAs from 228 cervical cancer
patients and 360 normal healthy controls were analysed with the polymerase chain
reaction-restriction fragment length polymosphism (PCR-RFLP) method.
Results : In the CYP 2El genotypes, detected by furl or PstI digestion, there were no
statistically remarkable differences between the cervical cancer patients and control
groups. And when the cervical cancer patients were divided into subgroups with respect
to the age, the frequency of CYP 231/Pst1 polymorphisms in the cervical cancer patients
under the 40 years old was not significantly higher compared to the controls or the
patients above the 40 years old and, cl/cl genotype was prominent in this type of
polymorphism. The frequency of CYP 2E1/PstI polymorphisms in the cervical cancer
patients was not significantly higher compared to the controls, and D/D genotype was
prominent in this type of polymorphism. In cervical carcinoma, the polymorphic
genotypes of CYP 2E 1 were not correlated to other parameters including clinical stage,
histological tumor type, and degree of differentiation.
Conclusion : These results suggest that individuals carrying CYP 2E1/PstI (cl/cl) or
CYP 2E1/DraI (D/D) alleles are not genetically susceptible to cervical cancer in Korea.

Å°¿öµå

Cervical cancer; Genetic susceptibility; Cytochrome P45O 2E 1;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS